1. Home >
  2. Companies >
  3. Life Science >
  4. United States >
  5. Washington >
  6. ZymoGenetics

ZymoGenetics - Ownership and Business Overview

Life ScienceCompany

ZymoGenetics Ownership

Who owns ZymoGenetics?

ZymoGenetics is owned by Bristol-Myers Squibb. It was acquired on September 7, 2010.

Was ZymoGenetics formerly PE-backed?

Yes. ZymoGenetics was formerly owned by 3 private investors.

ZymoGenetics Business Overview

Where is ZymoGenetics headquartered?

ZymoGenetics is headquartered in Seattle, Washington.

What sector is ZymoGenetics in?

ZymoGenetics is a life science company.

When was ZymoGenetics founded?

ZymoGenetics was founded in 1981.

Life Science M&A Summary in 2010

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2010. The largest life science acquisition in 2010 was Solvay Pharmaceuticals - which was acquired by Abbott Laboratories for $6.1B.

Subscribe to Mergr to view all 139 acquisitions of life science companies in 2010, including 16 acquisitions by private equity firms, and 123 by strategics.

ZymoGenetics, Inc.

1201 Eastlake Avenue East,
Seattle, Washington 98102-3702
United States,
(206)442-6600
www.zymogenetics.com

ZymoGenetics, Inc. is a biopharmaceutical company focused on the discovery and development of protein therapeutics that prevent or treat significant human diseases. The company launched its first product on the U.S. market in 2008 and has a strong pipeline of additional products in development.


Company Summary

SECTOR

Life Science

Established

1981

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for ZymoGenetics

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal